SCHEMBL23125643

SCHEMBL23125643

CC1(C)c2ccccc2N(c2ccccc2)c2ccc(C3(c4ccccc4)c4ccccc4S(=O)(=O)c4ccc(C#N)cc43)cc21

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.35
▸ MAPT P10636 1/20 0.32
▸ EGLN1 Q9GZT9 1/20 0.31
▸ OPRM1 P35372 1/20 0.30
▸ OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23125667 0.97 PGR (0.36) PGREGLN1OPRM1OPRL1
SCHEMBL22639879 0.95 PGR (0.39) PGRMAPT
SCHEMBL23125616 0.94 PGR (0.40) PGRMAPTEGLN1OPRM1OPRL1
SCHEMBL23125638 0.90 PGR (0.33) PGRMAPT
SCHEMBL23125644 0.85 TP53 (0.34) PGRMAPT
SCHEMBL22639825 0.82 PGR (0.45) PGRMAPT
SCHEMBL23125591 0.81 RXFP1 (0.35) MAPTEGLN1
SCHEMBL23125576 0.81 LMNA (0.33) EGLN1
SCHEMBL23125592 0.80 EGLN1 (0.32) EGLN1
SCHEMBL23125668 0.80 PGR (0.34) PGREGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954254-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10954254-B2 Heterocyclic compound and organic light-emitting device including the same TYR, DDT, LEF1 PGR 1871/4885MAPT 2730/4885EGLN1 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback